Koate-DVI (Antihemophilic factor [human]) for Hemophilia | MyHemophiliaTeam

Connect with others who understand.

sign up Log in
About MyHemophiliaTeam
Powered By

Koate-DVI is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Koate-DVI can also be used for perioperative (before, during, and after surgery) care. The technical name of Koate-DVI is Antihemophilic factor (human).

Koate-DVI is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.

How do I take it?
Prescribing information states that Koate-DVI is given as an intravenous injection.

Koate-DVI comes as a powder that must be reconstituted before injection.

Side effects
The FDA-approved label for Koate-DVI lists common side effects including blurred vision, tingling sensation, headache, abdominal pain, jitters, and nausea.

Rare but serious side effects listed for Koate-DVI include the transmission of infections.

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in